Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2005-04-01 (21 years)Status: ActiveBusiness sector: Fabrication de matériel médico-chirurgical et dentaireLocation: FOUGERES (35300), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EURL LABORATOIRE INCISAL : revenue, balance sheet and financial ratios
EURL LABORATOIRE INCISAL is a French company
founded 21 years ago,
specialized in the sector Fabrication de matériel médico-chirurgical et dentaire.
Based in FOUGERES (35300),
this company of category PME
shows in 2023 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EURL LABORATOIRE INCISAL (SIREN 482598588)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
1 620 041 €
N/C
N/C
N/C
N/C
N/C
Net income
6 408 €
35 718 €
21 510 €
37 322 €
94 112 €
45 821 €
57 281 €
70 681 €
EBITDA
N/C
N/C
64 208 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
1.3%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, EURL LABORATOIRE INCISAL generates positive net income of 6 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 71 k€ -> 6 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
6 408 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
12.876%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.238%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
41.152
58.846
43.434
49.253
33.44
22.717
20.954
12.876
Financial autonomy
53.995
52.054
57.176
47.929
58.802
65.944
65.378
69.238
Repayment capacity
None
None
None
None
None
2.336
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
3.574%
None%
None%
Sector positioning
Debt ratio
12.882025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Good-7 pts over 3 years
In 2025, the debt ratio of EURL LABORATOIRE INCISAL (12.88) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
69.24%2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Excellent
In 2025, the financial autonomy of EURL LABORATOIRE INCISAL (69.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.34 years2023
2023
Q1: 0.0 years
Med: 0.51 years
Q3: 2.03 years
Average
In 2023, the repayment capacity of EURL LABORATOIRE INCISAL (2.34) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 368.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
276.734
409.405
388.791
282.755
376.168
425.271
380.857
368.033
Interest coverage
None
None
None
None
None
3.721
None
None
Sector positioning
Liquidity ratio
368.032025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Excellent
In 2025, the liquidity ratio of EURL LABORATOIRE INCISAL (368.03) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.72x2023
2023
Q1: 0.0x
Med: 0.81x
Q3: 4.71x
Good
In 2023, the interest coverage of EURL LABORATOIRE INCISAL (3.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution EURL LABORATOIRE INCISAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
279 700 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
13
0
0
Customer payment term (days)
0
0
0
0
0
32
0
0
Supplier payment term (days)
0
0
0
0
0
24
0
0
Positioning of EURL LABORATOIRE INCISAL in its sector
Comparison with sector Fabrication de matériel médico-chirurgical et dentaire
Valuation estimate
Based on 57 transactions of similar company sales
(all years),
the value of EURL LABORATOIRE INCISAL is estimated at
19 516 €
(range 4 535€ - 38 486€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2025
57 tx
4k€19k€38k€
19 516 €Range: 4 535€ - 38 486€
NAF 5 all-time
Valuation method used
Net Income Multiple
6 408 €
×
3.0x
=19 517 €
Range: 4 535€ - 38 486€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de matériel médico-chirurgical et dentaire)
Compare EURL LABORATOIRE INCISAL with other companies in the same sector:
Frequently asked questions about EURL LABORATOIRE INCISAL
What is the revenue of EURL LABORATOIRE INCISAL ?
The revenue of EURL LABORATOIRE INCISAL in 2023 is 1.6 M€.
Is EURL LABORATOIRE INCISAL profitable?
Yes, EURL LABORATOIRE INCISAL generated a net profit of 6 k€ in 2025.
Where is the headquarters of EURL LABORATOIRE INCISAL ?
The headquarters of EURL LABORATOIRE INCISAL is located in FOUGERES (35300), in the department Ille-et-Vilaine.
Where to find the tax return of EURL LABORATOIRE INCISAL ?
The tax return of EURL LABORATOIRE INCISAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EURL LABORATOIRE INCISAL operate?
EURL LABORATOIRE INCISAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart